19 October 2026

strategyland.uk

Baillie Gifford US Growth Trust PLC (USAB)

Rank #239 of 280 - Financials - UK Equities

Home/Stocks/Financials

Baillie Gifford US Growth Trust PLC

USAB.L·Financials·Market Cap £1.1b

Rank #239 of 280

Quantitative Model · 280 Stocks Analysed

£3.90

+34.31% YTD

52W: £2.61 - £3.98

Factor Analysis Summary

Editorial assessment generated from Baillie Gifford US Growth Trust PLC's live factor scores and sector positioning.

Based on Strategyland's proprietary 7-factor analysis, Baillie Gifford US Growth Trust PLC (USAB.L) currently holds an overall rank of #239 out of 280 FTSE 100 constituents, reflecting its weighted composite score across liquidity, valuation, profitability, solvency, asset efficiency, market trading, and technical dimensions.

Key strengths include valuation (P/E 4.7), where it demonstrates compelling valuation metrics, trading at a discount to peer averages on key multiples; market trading, where it demonstrates strong market trading characteristics with favourable volume trends and institutional participation; and solvency (debt/equity 0.0), where it demonstrates a robust solvency position with conservative leverage and strong balance sheet coverage.

Areas requiring attention include liquidity, where thin trading volumes could increase transaction costs and slippage, as well as asset efficiency, where asset efficiency is average and does not contribute meaningfully to the composite score.

Within the Financials sector, Baillie Gifford US Growth Trust PLC sits at composite rank #239, trailing the Financials peer average (rank 8). It ranks behind all 6 tracked Financials peers in our model.

Despite its mid-table composite rank of #239, Baillie Gifford US Growth Trust PLC shows selective strength — notably in valuation and market trading — suggesting a stock with identifiable merits alongside clear areas for improvement.

Strongest Factors

Valuation — Rank 21/280 (top quartile)
Market Trading — Rank 25/280 (top quartile)
Solvency — Rank 28/280 (top quartile)

Weakest Factors

Liquidity — Rank 276/280 (below average)
Asset Efficiency — Rank 129/280 (middle of the pack)

Score Analysis

Baillie Gifford US Growth Trust PLC is ranked #239 out of 280 UK stocks. Lower factor scores indicate better performance in that category.

Factor Breakdown

95/280

Average Score

Liquidity

Weak276/280

Valuation

Excellent21/280

Profitability

Excellent64/280

Solvency

Excellent28/280

Asset Efficiency

Fair129/280

Mkt Trading

Excellent25/280

Technical

Fair120/280

1. Liquidity

Score: 276/280

How liquid is USAB and can it meet its short-term obligations?

0/6

liquidity criteria met

Metric

Sector Range

Value

Rank

–

Quick Ratio

N/A

Range: N/A

–

Current Ratio

N/A

0.26xRank 237/280

Range: N/ARank 237/280

–

TTM Operating Cash Flow

N/A

-0.17xRank 230/280

Range: N/ARank 230/280

–

Liquidity Coverage Ratio

100-150

N/A

Range: 100-150

–

Intangible Asset Ratio

10 - 30

N/ARank 193/280

Range: 10 - 30Rank 193/280

–

Cash-to-Debt Ratio

N/A

0.15xRank 181/280

Range: N/ARank 181/280

Key Liquidity Metrics

Quick Ratio

N/A

Sector: N/A

Current Ratio

0.26x

Sector: N/A

Overall Liquidity Rank

Rank within universe#276/280

Best (1)Worst (280)

2. Valuation

Score: 21/280

Is USAB undervalued compared to its peers and fair value metrics?

2/7

valuation criteria met

Metric

Sector Range

Value

Rank

–

FY27e P/E

8x - 18x

N/A

Range: 8x - 18x

–

FY26e P/E

8x - 18x

N/A

Range: 8x - 18x

–

FY27e Net Div Yld (%)

3.0 - 8.0

N/A

Range: 3.0 - 8.0

–

Div Payout Ratio

30 - 55

N/ARank 50/280

Range: 30 - 55Rank 50/280

–

Current EV/EBITDA

N/A

4.3xRank 40/280

Range: N/ARank 40/280

✓

Current P/TBV

0.8x - 2.0x

1.00xRank 86/280

Range: 0.8x - 2.0xRank 86/280

✓

Current P/B

0.8x - 2.0x

1.00xRank 100/280

Range: 0.8x - 2.0xRank 100/280

Key Valuation Metrics

TTM P/E

Price-to-Earnings

4.7x

FY26e P/E

Forward estimate

N/A

FY27e P/E

Forward estimate

N/A

Current P/B

Price-to-Book

1.00x

Current P/TBV

Tangible Book Value

1.00x

Current EV/EBITDA

Enterprise Value

4.3x

FY26e EV/EBITDA

Forward estimate

N/A

FY27e EV/EBITDA

Forward estimate

N/A

Dividend

USAB does not currently pay a significant dividend.

—

No dividend data available for this stock.

3. Profitability

Score: 64/280

How profitable is USAB relative to its peers?

0/7

profitability criteria met

Metric

Sector Range

Value

Rank

✗

TTM Profit Margin

15 - 30

96.6%Rank 14/280

Range: 15 - 30Rank 14/280

–

T12 FCF Margin

N/A

-0.8%Rank 240/280

Range: N/ARank 240/280

–

FY27e RoE

10 - 16

N/A

Range: 10 - 16

–

FY26 EPS Growth

8 - 15

N/A

Range: 8 - 15

–

FY27e EPS Growth

6 - 12

N/A

Range: 6 - 12

–

NIM

1.5 - 3.2

N/A

Range: 1.5 - 3.2

–

Expense Ratio

50 - 65

N/A

Range: 50 - 65

TTM Profit Margin

96.6%

Current RoCE

26.6%

FY27e RoE

N/A

T12 FCF Margin

-0.8%

4. Solvency

Score: 28/280

How strong is USAB's balance sheet and financial position?

0/6

solvency criteria met

Metric

Sector Range

Value

Rank

✗

Debt/Eqt

0.5x - 1.5x

0.04xRank 28/280

Range: 0.5x - 1.5xRank 28/280

–

Interest Coverage Ratio

N/A

Rank 22Rank 22/280

Range: N/ARank 22/280

–

Net Leverage Ratio

N/A

Range: N/A

–

Altman Z-Score (Manufacturing)

N/A

26.71Rank 27/280

Range: N/ARank 27/280

–

Z-Score (Non Manufacturing)

N/A

Rank 29Rank 29/280

Range: N/ARank 29/280

–

CapAdeq Ratio Tier1

13 - 18

N/A

Range: 13 - 18

Key Solvency Metrics

Debt/Eqt

0.04x

Net Leverage Ratio

N/A

Interest Coverage

Rank 22

T12 FCF Margin

-0.8%

Altman Z-Score

26.71

Safe Zone

01.812.995+

5. Asset Efficiency

Score: 129/280

How efficiently does USAB deploy its assets and intellectual capital?

0/5

asset efficiency criteria met

Metric

Sector Range

Value

Rank

–

Efficiency Ratio

50 - 70

N/A

Range: 50 - 70

–

TTM Asset Turnover Ratio

N/A

0.26xRank 171/280

Range: N/ARank 171/280

✗

TTM CAPEX/Sales

1 - 3

93.5%Rank 7/280

Range: 1 - 3Rank 7/280

–

Working Capital Turnover

N/A

Range: N/A

–

R&D/Sales FY27e

N/A

Range: N/A

Overall Asset Efficiency Rank

Rank within sector peers#129/280

Best (1)Worst (280)

6. Market Trading

Score: 25/280

How liquid and actively traded is USAB?

1/2

market trading criteria met

Metric

Sector Range

Value

Rank

–

Intraday Sentiment (%)

40 - 75

N/A

Range: 40 - 75

–

10D-Avg v/s 3M-Avg Vol

N/A

139%Rank 50/280

Range: N/ARank 50/280

✓

Avg Directional Index 30D

012 - 45

30.5Rank 29/280

Range: 012 - 45Rank 29/280

–

Parabolic SAR

N/A

381.62Rank 180/280

Range: N/ARank 180/280

–

Stock Rating Rank

N/A

Range: N/A

Market Cap

£1,077,268,677

Enterprise Value

£1,072,457,812

Trading Volume

7. Technical

Score: 120/280

What do the technical indicators say about USAB?

0/5

technical criteria met

Metric

Chart

Sector Range

Value

Rank

–

CMP v/s 52-WH

£3.98£2.61

-2.1%CMP: £3.90

N/A

-2.1%Rank 21/280

£3.98£2.61

-2.1%CMP: £3.90

Range: N/ARank 21/280

–

CMP v/s 52-WL

£3.98£2.61

+49.2%CMP: £3.90

N/A

49.2%Rank 216/280

£3.98£2.61

+49.2%CMP: £3.90

Range: N/ARank 216/280

–

RSI 14D

070.5 - Overbought100

N/A

70.5Rank 25/280

070.5 - Overbought100

Range: N/ARank 25/280

–

MA50 - MA200

£3.19+0.32£3.51

N/A

BullishRank 98/280

£3.19+0.32£3.51

Range: N/ARank 98/280

–

MACD Rank

Golden Cross

MACD: 0.10

N/A

0.10Rank 100/280

Golden Cross

MACD: 0.10

Range: N/ARank 100/280

RSI (14 Day)

70.5

Overbought

0 (Oversold)50100 (Overbought)

Moving Averages

50 SMA£3.51

200 SMA£3.19

SignalGolden Cross (Bullish)

MACD0.10

Risk Metrics

Beta

N/A

3-Yr Std Dev

N/A

5-Yr Std Dev

N/A

Peer Comparison

How does USAB compare to other Financials stocks?

Overall Rank Comparison

Factor Score Comparison

Stock	Rank	Liquidity	Valuation	Profitability	Solvency	Mkt Trading	Technical
USAB	#239	276	21	64	28	25	120
MUT.L	#3	128	38	24	56	27	8
RTW.L	#5	116	7	9	145	69	229
BPCR.L	#7	163	34	56	9	112	76
RCP.L	#9	179	26	22	59	13	2
AGT.L	#11	108	57	55	72	90	79
TBCG.L	#14	29	55	38	257	129	18

Similar Stocks

Other top-ranked stocks in the Financials sector

View all

MUT.L

Murray Income Trust PLC

Rank #3Score: 47

RTW.L

RTW Biotech Opportunities Ltd

RIT Capital Partners PLC

Catch Healthcare Events Before the Market Moves

SEC filings, FDA approvals, clinical trials, and regulatory events - scored for significance across 4 global markets.

Methodology Note

The analysis presented for Baillie Gifford US Growth Trust PLC is produced using Strategyland's proprietary 7-factor quantitative model, which evaluates each stock across Liquidity, Valuation, Profitability, Solvency, Asset Efficiency, Market Trading, and Technical dimensions. Individual factor scores and the composite rank reflect relative rankings within the FTSE 100 universe — a lower rank number indicates stronger performance in that category.

Underlying financial and market data is sourced from LSEG (London Stock Exchange Group) and processed through our scoring engine. Scores are recalculated as new data becomes available and should be interpreted as a systematic screening output, not a forecast of future share price performance.

This content is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Past performance and factor rankings are not indicative of future results. Please read our Risk Disclaimer before making any investment decisions.

Strategyland Research Center - strategyland.ukThis report is for informational purposes only. Not financial advice.